Receptor autoimmunity: diagnostic and therapeutic implications

Area of Science:

• Immunology
• Endocrinology
• Neurology

Background:

• Receptor autoimmunity is a significant category of autoimmune diseases.
• Key examples include Graves' disease, myasthenia gravis, idiopathic membranous nephropathy, and autoimmune encephalitis.
• These conditions are characterized by autoantibodies against cell-surface receptors like TSH, acetylcholine, phospholipase 2, and NMDA receptors.

Purpose of the Study:

• To outline the distinct features of receptor autoimmunity.
• To explore the relationship between autoimmunology laboratories and autoantibody detection.
• To emphasize the diagnostic and prognostic importance of autoantibody measurement.

Main Methods:

• Review of immunological features of receptor autoimmunity.
• Discussion of T cell-dependent, B cell-mediated autoimmune mechanisms.
• Emphasis on the role of autoantibody detection and quantification.

Main Results:

• Autoantibodies against cell-surface receptors are crucial in diagnosing and understanding receptor autoimmunity.
• Measurement of autoantibodies aids in differential diagnosis between autoimmune and non-autoimmune conditions.
• Quantitative immunoassays are preferred over semi-quantitative methods for precision.

Conclusions:

• Accurate measurement of autoantibodies is central to diagnosing receptor autoimmune diseases.
• Understanding autoantibody concentration correlates with disease intensity and progression.
• Quantitative immunoassays provide superior diagnostic accuracy and reference range definition.